Escherichia coli, is one of the most widely preferred organism for the production of recombinant protein. Most of the FDA approved therapeutic proteins are produced in E. coli. The well-established cell factory of E. coli makes it a perfect heterologous system of choice for the production of recombinant proteins. In recent years, several advances have been taken place for modifying these cell factories for easy production of therapeutic proteins with utmost precision. Several molecular tools and protocols are available in hand for the high level protein production in heterologous expression system. Adapting the best strategy for producing recombinant proteins in E. coli can be obtained using several approaches. Combination of strategies will work well to enhance the expression and stability of produced protein. In this review we try to collate different strategies and approaches that can enhance the production as well as the stability of proteins expressed in E. coli.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.